Relaxin/RXFP1 Signaling in Prostate Cancer Progression
Shu Feng(University of Southern California), Alexander I. Agoulnik(Florida International University), Hee Dong Han(IMEC), Michael Ittmann(Baylor College of Medicine), Zhen Li(Tongji Hospital), Gabriel Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Irina U. Agoulnik(University of South Florida)
Cited by 25
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
|New England Journal of Medicine|2008|719